Cargando…

Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands

A novel series of antimony (V) complexes with the hydroxypyranone and hydroxypyridinone ligands were synthesized and characterized by (1)HNMR, FT-IR and electron spin ionization mass spectroscopic (ESI-MS) techniques. The synthesis process involved protection of hydroxyl group followed by the reacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheikhmoradi, Vafa, Saberi, Sedigheh, Saghaei, Lotfollah, Pestehchian, Nader, Fassihi, Afshin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842482/
https://www.ncbi.nlm.nih.gov/pubmed/29606965
http://dx.doi.org/10.4103/1735-5362.223793
_version_ 1783304902970179584
author Sheikhmoradi, Vafa
Saberi, Sedigheh
Saghaei, Lotfollah
Pestehchian, Nader
Fassihi, Afshin
author_facet Sheikhmoradi, Vafa
Saberi, Sedigheh
Saghaei, Lotfollah
Pestehchian, Nader
Fassihi, Afshin
author_sort Sheikhmoradi, Vafa
collection PubMed
description A novel series of antimony (V) complexes with the hydroxypyranone and hydroxypyridinone ligands were synthesized and characterized by (1)HNMR, FT-IR and electron spin ionization mass spectroscopic (ESI-MS) techniques. The synthesis process involved protection of hydroxyl group followed by the reaction of the intermediate with primary amines and finally deprotection. All compounds were evaluated for in vitro activities against the amastigote and promastigote forms of Leishmania major. Most of the synthesized compounds exhibited good antileishmanial activity against both forms of L. major. IC(50) values of the most active compounds; 9d, 9d and 9e, after 24, 48 and 72 h against amastigote model were 15, 12.5 and 5.5 μg/mL, respectively. 9e, 11 and 9e inhibited the promastigote form of parasite after 24, 48 and 72 h with IC(50) values of 10, 2 and 1 μg/mL, respectively.
format Online
Article
Text
id pubmed-5842482
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-58424822018-04-01 Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands Sheikhmoradi, Vafa Saberi, Sedigheh Saghaei, Lotfollah Pestehchian, Nader Fassihi, Afshin Res Pharm Sci Original Article A novel series of antimony (V) complexes with the hydroxypyranone and hydroxypyridinone ligands were synthesized and characterized by (1)HNMR, FT-IR and electron spin ionization mass spectroscopic (ESI-MS) techniques. The synthesis process involved protection of hydroxyl group followed by the reaction of the intermediate with primary amines and finally deprotection. All compounds were evaluated for in vitro activities against the amastigote and promastigote forms of Leishmania major. Most of the synthesized compounds exhibited good antileishmanial activity against both forms of L. major. IC(50) values of the most active compounds; 9d, 9d and 9e, after 24, 48 and 72 h against amastigote model were 15, 12.5 and 5.5 μg/mL, respectively. 9e, 11 and 9e inhibited the promastigote form of parasite after 24, 48 and 72 h with IC(50) values of 10, 2 and 1 μg/mL, respectively. Medknow Publications & Media Pvt Ltd 2018-04 /pmc/articles/PMC5842482/ /pubmed/29606965 http://dx.doi.org/10.4103/1735-5362.223793 Text en Copyright: © 2018 Research in Pharmaceutical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sheikhmoradi, Vafa
Saberi, Sedigheh
Saghaei, Lotfollah
Pestehchian, Nader
Fassihi, Afshin
Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands
title Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands
title_full Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands
title_fullStr Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands
title_full_unstemmed Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands
title_short Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands
title_sort synthesis and antileishmanial activity of antimony (v) complexes of hydroxypyranone and hydroxypyridinone ligands
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842482/
https://www.ncbi.nlm.nih.gov/pubmed/29606965
http://dx.doi.org/10.4103/1735-5362.223793
work_keys_str_mv AT sheikhmoradivafa synthesisandantileishmanialactivityofantimonyvcomplexesofhydroxypyranoneandhydroxypyridinoneligands
AT saberisedigheh synthesisandantileishmanialactivityofantimonyvcomplexesofhydroxypyranoneandhydroxypyridinoneligands
AT saghaeilotfollah synthesisandantileishmanialactivityofantimonyvcomplexesofhydroxypyranoneandhydroxypyridinoneligands
AT pestehchiannader synthesisandantileishmanialactivityofantimonyvcomplexesofhydroxypyranoneandhydroxypyridinoneligands
AT fassihiafshin synthesisandantileishmanialactivityofantimonyvcomplexesofhydroxypyranoneandhydroxypyridinoneligands